Intriguingly, ID2 showed the least propensity among all signatures (Supplementary Fig. 26), which indicates a diminished predisposition for immunoediting, likely contributing to the observed shorter latency and accelerated tumor proliferation. This evidence concerns the gene ID2 and neoplasm.